Watch International Care Company SpA for free: we tell you when fair value or trend changes.

International Care Company SpA (ICC) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of International Care Company SpA stock €1.49, price €1.02, upside +46.1%, quality 60 out of 100. Rating: undervalued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.

11 models, one by oneBear €0.9400 to bull €2.25 Growth analysisrevenue history, year by year Quality 60/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials IT · ISIN IT0005469371

Thin data Nov 4, 2026

International Care Company SpA

ICC · MI

Undervalued, but in a downtrend

The stock costs 32% less than our calculation considers fair.

Fair value €1.49 · Undervalued

Quality 60/100

Low debt

Generates free cash flow

Mixed Growth (revenue 5y +15.8 %/yr in EUR)

Mixed vs. peers (5/11)

Loss-making · -5.9% net margin (TTM)

Narrow moat 8/100 · thin data

Thin data

Watch International Care Company SpA for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

58‑month range €0.9600 – €2.96 · fair‑value band €0.9400 – €2.25 · the €1.02 price screens below the €1.49 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.

Follow International Care Company SpA in your weekly email

Every Wednesday you see whether International Care Company SpA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

International Care Company S.p.A. provides digital health care assistance services in Italy and internationally.

Show moreShow less

It offers medical assistance services, including telephone medical consultation, home delivery of medicines, medical dispatch at home, doctor and pediatrician/cardiologist home visit, second medical opinion, manages appointment of doctors through the operational center, online medical passport, and medical record translation services; and home assistance services comprising emergency locksmith and hydraulic dispatch, emergency dispatch electrician, pet assistance, veterinary advice, credit card blocking and replacement, and supervision and custody of assets, as well as services related to damage to the house, expenses for remaking documents, save documents, and sending craftsman for bricklayer, glazier, etc.

The company also provides travel assistance services, such as ticket office and hotel accommodation, medical transport, early return, repatriation of the body, repetition of the trip, medical dispatch at home, medical consultation, home delivery of medicines, and babysitting services, as well as services related to advance expenses for basic necessities; and auto assistance services consisting of roadside assistance, repatriation of the vehicles, car replacement, sending driver or taxi, organization of the return trip, sending spare parts, hotel expenses, advance of money, mechanical dispatch, and ambulance transport.

In addition, it offers telemonitoring service and video call with doctors, call and satellite centers, and claims management services. The company was founded in 2018 and is headquartered in Agrate Brianza, Italy. International Care Company S.p.A. operates as a subsidiary of FD Holding S.p.A.

Stock analysis

International Care Company SpA (ICC) currently trades at €1.02, while our model-based Fair Value estimate is €1.49, implying the stock looks roughly 32% undervalued today.

Valuation

Bull case: the DCF Models group reads highest at a median of €1.45 per share, and 9 of the 11 models we run sit above the €1.02 price.

Bear case: the Asset-Based group reads lowest at €0.2200, and 2 of the 11 models stay below the price. Data coverage for this calculation is low.

Scenario range: €0.9400 (bear) to €2.25 (bull), the price of €1.02 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

International Care Company SpA reported revenue of €9.4M in FY2025 versus €4.6M in FY2021, a compound +19.2%/yr. Reported net income was −€566K in FY2025.

Key figures

Market cap €4.9M Micro · P/S ratio 0.53 · EPS (TTM) €−0.1200 · Net margin −5.9% · Return on equity −15.3% · Return on assets (EBIT) −10.0% (5-year average) · Operating margin −10.0% · Revenue (TTM) €9.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 29% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −13% fair-value upside, at 46%, ICC screens cheaper than that median.

Fair Value models

Bear €0.9400 Fair Value €1.49 Bull €2.25

Price €1.02 · Upside +46.1%

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Best data coverage

FCF DCF €0.9400 €1.49 €2.65 78

Growth DCF €0.9100 €1.49 €2.25 77

Owner Earnings €0.3800 €0.5900 €0.9200 75

All 11 models by family

DCF Models

FCF DCF €0.9400 €1.49 €2.65 78

Owner Earnings €0.3800 €0.5900 €0.9200 75

5Y Revenue Exit €0.8300 €1.40 €2.18 71

5Y EBITDA Exit €0.9900 €1.75 €2.75 73

10Y Revenue Exit €0.8400 €1.37 €2.22 65

10Y EBITDA Exit €0.9600 €1.60 €2.65 66

Multiples

EV/EBITDA €1.10 €1.42 €1.75 67

EV/Revenue €0.7700 €1.05 €1.34 54

Asset-Based

NCAV (Graham) €0.1400 €0.2200 €0.2700 54

Growth DCF

Growth DCF €0.9100 €1.49 €2.25 77

Rev-Margin DCF €0.8300 €1.38 €2.14 71

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 40

How much profit the company makes from its sales and capital

Quality Growth 81

Are margins and returns getting better?

Cashflow 28

Do the profits arrive as real cash?

Financial strength 71

Debt, balance sheet and risk of trouble

Investment 96

Does it invest with discipline instead of growing at any price?

Low Volatility 58

How calm the share price moves, does not count

Price momentum 20

Price momentum of the last 3 to 12 months, does not count

Near the 52-week high 12

Distance to the 52-week high, does not count

New shares 73

Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+10.7%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+19.1%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+15.8%

Start year 2020 (pandemic)

Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+3.7%

’19

’20

’21

’22

’23

’24

’25

Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.

−20.8% (2020) → −4.4% (2025)

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss

not computed

Growth Forecast

Little optimism in the price

The price assumes less growth than the company has delivered so far.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+8.0%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect

n/a

No analyst forecast available.

After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about +5.7% a year for the price.

Watch ICC, get fair value alerts →

Compare International Care Company SpA with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 229 stocks

Beats the industry median on 4/9 measures

A mixed picture versus its industry peers.

Valuation

Quality Score 60 · Above median

Fair Value upside +46.1% · Above median

Profitability

Return on assets −9.0% · Bottom 25%

Net margin (12 months) −5.9% · Bottom 25%

Operating margin (12 months) −10.0% · Bottom 25%

Growth and dividend

Revenue growth (quarter YoY) 1.3% · Below median

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/B 1.29× · Cheaper than median

P/S (12 months) 0.52× · Cheaper than median

Price / free cash flow (fiscal year) 14.1× · Pricier than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)95 · sector 44

FUTURE (revenue growth)7 · sector 33

PAST (return on equity)0 · sector 38

HEALTH (low debt)100 · sector 94

DIVIDEND (yield)0 · sector 57

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value	Compare
Copart, Inc CPRT	$31.95	$35.73	+12%	vs ICC
RB Global, Inc RBA	C$131.85	C$146.29	+11%	vs ICC
Wolters Kluwer N.V WKL	€90.08	€98.05	+9%	vs ICC
Global Payments Inc GPN	$97.40	$87.84	−10%	vs ICC
Brambles Limited BXB	A$21.79	A$18.94	−13%	vs ICC
Cintas Corporation CTAS	$222.36	$188.90	−15%	vs ICC
Rentokil Initial plc RTO	$23.61	$19.63	−17%	vs ICC
Thomson Reuters Corporation TRI	$112.57	$70.75	−37%	vs ICC
Aramark ARMK	$52.54	$23.04	−56%	vs ICC
UL Solutions Inc ULS	$78.65	$33.46	−57%	vs ICC

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks Undervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator

Run the numbers yourself: free valuation calculators

DCF Calculator P/E Ratio Calculator PEG Ratio Calculator Graham Number Peter Lynch Formula DDM Calculator Intrinsic Value Intrinsic vs Extrinsic Value P/E Ratio by Sector

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

International Care Company SpA: fair value per Fair Value Calculator

<a href="https://www.fairvalue-calculator.com/stock/ICC.MI?utm_source=embed&amp;utm_medium=badge" target="_blank" rel="nofollow noopener"><img src="https://www.fairvalue-calculator.com/embed/ICC.MI.svg" width="360" height="84" alt="International Care Company SpA: fair value per Fair Value Calculator" style="border:0;max-width:100%" loading="lazy"></a>

Cite: Fair Value Calculator (2026). "International Care Company SpA Fair Value". https://www.fairvalue-calculator.com/stock/ICC.MI

Frequently asked questions

Is International Care Company SpA (ICC) overvalued or undervalued?

As of Nov 4, 2026, our model estimates a fair value of €1.49 versus a price of €1.02, about +46% upside (undervalued).

What is the fair value of ICC?

Our model-based fair value for International Care Company SpA is €1.49 (as of Nov 4, 2026), built from audited fundamentals. The current price: €1.02.

What is the quality score of ICC?

International Care Company SpA has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for International Care Company SpA (ICC)?

Our model-based price target is the fair value of €1.49 (as of Nov 4, 2026) from 11 valuation models. Cautious scenario €0.9400, optimistic scenario €2.25. It is a calculation from audited fundamentals, not an analyst target.

What is the International Care Company SpA stock forecast for 2026?

Our models put fair value at €1.49, about +46% upside versus a price of €1.02 (undervalued). Cautious scenario €0.9400, optimistic scenario €2.25. The calculation is refreshed regularly with new filings.

What is the revenue of International Care Company SpA (ICC)?

International Care Company SpA reported trailing-twelve-month revenue of about €9.4M (latest available figure, as of Nov 4, 2026).

What growth is priced into International Care Company SpA (ICC)?

For today's price to be fair in a discounted-cash-flow model, International Care Company SpA would have to grow free cash flow by +8.0 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.8 % per year. As of Nov 4, 2026.

What discount rate (WACC) does the fair value of ICC use?

Our models discount International Care Company SpA at 12.0 %: a base by market capitalisation (nano), damped by beta 1.01, country premium for Italy. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For International Care Company SpA that is +8.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.0 %) and the same formula as our fair value.

How much growth has International Care Company SpA (ICC) delivered so far?

Over the past 5 years revenue at International Care Company SpA grew +15.8 % a year. The price currently implies free-cash-flow growth of +8.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of International Care Company SpA (ICC) growing?

The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into International Care Company SpA (+8.0 % per year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of International Care Company SpA (ICC)?

The free-cash-flow yield on the price is 7.08 %: that much free cash flow International Care Company SpA produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of International Care Company SpA (ICC)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For International Care Company SpA it is €1.49 per share (as of Nov 4, 2026), against a price of €1.02. It is the blended result of 11 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).

Is International Care Company SpA stock overvalued or undervalued in 2026?

As of Nov 4, 2026, ICC trades below its calculated fair value: price €1.02, fair value €1.49, a gap of about +46% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of ICC?

No. The price is what the market pays today (€1.02); the fair value is what the company's own numbers justify (€1.49). For International Care Company SpA the two are €0.4700 per share apart. That gap is exactly why we show both numbers side by side.

How much is International Care Company SpA worth?

The market values International Care Company SpA at about €4.9M (market capitalisation, as of Nov 4, 2026). Per share that is €1.02; our models calculate a fair value of €1.49 per share.

What do the bullish and bearish scenarios say about ICC?

Our models span a range for International Care Company SpA: cautious scenario €0.9400, base €1.49, optimistic €2.25 per share (as of Nov 4, 2026, price €1.02). The range comes from different growth and margin assumptions, not from analyst opinions.

How solid is the balance sheet of International Care Company SpA (ICC)?

Balance-sheet figures for International Care Company SpA (as of Nov 4, 2026): return on equity −15.3%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.

How far is ICC from its 52-week high?

International Care Company SpA trades at €1.02, about 29% below its 52-week high of €1.44 and 4% above the low of €0.9850 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of €1.49 is for.

Which stocks are comparable to International Care Company SpA?

From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is International Care Company SpA stock attractive at the current price?

The data as of Nov 4, 2026: price €1.02, calculated fair value €1.49 (+46%), Quality Score 60/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of ICC calculated?

We run International Care Company SpA through 11 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of €1.49 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 13.3% above its aggregate fair value. International Care Company SpA currently trades 32% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of International Care Company SpA (ICC)?

The closing price on Nov 6, 2026 was €1.02. Our model-based fair value is €1.49, about +46% upside (undervalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with International Care Company SpA right now?

The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (€0.9400 to €2.25) leaves room in how you read the outcome.

Key figures of International Care Company SpA

How large is the market capitalisation of International Care Company SpA (ICC)?

The market capitalisation of International Care Company SpA is €4.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of International Care Company SpA (ICC)?

The price-to-sales ratio of International Care Company SpA is 0.53 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of International Care Company SpA (ICC)?

Earnings per share at International Care Company SpA are €−0.1200. Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of International Care Company SpA (ICC)?

The net margin of International Care Company SpA is −5.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of International Care Company SpA (ICC)?

The return on equity (ROE) of International Care Company SpA is −15.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of International Care Company SpA (ICC)?

On an EBIT basis the return on assets of International Care Company SpA is −10.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of International Care Company SpA (ICC)?

The operating margin of International Care Company SpA is −10.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at International Care Company SpA (ICC)?

Revenue at International Care Company SpA is growing +1.3% versus a year earlier (3y avg +19.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

Free · no account needed

Watch International Care Company SpA in the live analysis

One click puts International Care Company SpA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.